Match Document Document Title
7582770 Viral polymerase inhibitors  
An enantiomer, diastereoisomer or tautomer of a compound, represented by formula I: wherein A, B, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , and R 10 are as defined herein, or a...
7579338 Methods and compositions for treating atheroma, tumors and other neoplastic tissues  
The radiation sensitization potential of a candidate compound can be screened by determine its ability to generate one or more reactive oxygen species under appropriate conditions. Compounds...
7547689 Methods and compositions for treating atheroma, tumors and other neoplastic tissues  
Compositions comprising motexafin gadolinium, as well as methods for using these compositions in the treatment of brain metastases, are described herein.
7534807 De novo synthesis of bacteriochlorins  
A method of making a bacteriochlorin is carried out by condensing a pair of compounds of Formula II to produce the bacteriochlorin, wherein R is an acetal or aldehyde group. The condensing may...
7491831 PPAR active compounds  
Compounds are described that are active on PPARs, including pan-active compounds. Also described are methods for developing or identifying compounds having a desired selectivity profile.
7488817 Metal complex protein kinase inhibitors  
This inventive subject matter relates to novel metal complex protein kinases inhibitors, methods for making such compounds, and methods for using such compounds for treating diseases and disorders...
7485320 Liposome for incorporating large amounts of hydrophobic substances  
A liposome formulation for stably incorporating high content of hydrophobic substance is disclosed. The liposome includes two phospholipids with different phase transition temperatures such as...
7482472 Substituted isoindoles and their use  
The invention relates to coagulation of the blood. Disclosed are novel compounds of formula (I), a method for the production of these compounds, pharmaceutical compositions containing them, and...
7449454 Metallotexaphyrin derivatives  
Novel derivatives of metallotexaphyrins are prepared by modifying the apical ligands associated with the central metal component of a metallotexaphyrin.
RE40558 Therapeutic uses of di-aryl acid derivatives  
The use of diaryl acid derivatives of formula (I) or pharmaceutically acceptable salts, N-oxides, hydrates or solvates thereof, wherein the variables shown are defined in the disclosure, and...
7423056 Tricyclic heteroaryl piperazines, pyrrolidines and azetidines as serotonin receptor modulators  
The present invention generally relates to a series of compounds, to pharmaceutical compositions containing the compounds, and to use of the compounds and compositions as therapeutic agents. More...
7414069 Antituberculosis compounds, Hirsutellones A, B, and C  
Three new alkaloids, Hirsutellones A, B, and C, are produced in cultures of fungus such as Hirsutella nivea strain BCC 2594 and Trichoderma sp. strain BCC 7579. The Hirsutellones exhibited...
7410978 Once daily dosage forms of trospium  
A pharmaceutical composition of a pharmaceutically acceptable trospium salt, with upon administration to a human patient generates an average steady state blood levels of trospium with a minimum (C...
7390821 Methods of reducing angiogenesis  
The present invention provides methods of reducing angiogenesis in an individual. The methods generally involve administering to the individual an effective amount of a nicotinic acetyl choline...
7388024 Indeno[2,1A]indenes and isoindolo[2,1-A]indoles  
The present invention provides indeno[2,1a]indene and isoindolo[2,1-a]indole derivatives of the Formula I, its salts and its stereoisomers, wherein X, R 1 , R 2 , R 3 , R 4 , R 6 , R 7 , R 8 , R 9...
7371742 Porphyrin derivatives for photodynamic therapy  
This invention relates to porphyrin compounds used to destroy or impair the functioning of a target biological material in photodynamic therapy, in particular against virus, tumoral cells,...
7354947 Isothiazoloanthrones, isoxazoloanthrones, isoindolanthrones and derivatives thereof a JNK inhibitors and compositions and methods related thereto  
Isaothiazoloanthrones, isooxazoloanthrones, isoindolanthrones, and derivatives thereof having the general formula: and pharmaceutically acceptable salts thereof, wherein R 0 is —CH 2...
7348361 Solution for diagnosing or treating tissue pathologies  
The invention concerns a 5-aminolevulinic acid ester (E-ALA) solution for producing a pharmaceutical preparation useful for diagnosing and/or treating tissue and/or cell pathologies by local...
7348352 Diindolylmethane for the treatment of HPV infection  
New methods and compositions are disclosed that comprise the phytochemical Diindolylmethane, alone or in combination with immune potentiating steroids. These methods and compositions are utilized...
7345034 Azacyclosteroid histamine-3 receptor ligands  
Azacyclosteroid histamine-3 receptor ligands, pharmaceutical compositions comprising such compounds, and methods for using such compounds and compositions are described herein.
7338973 Tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators  
The present invention is directed to novel tetracyclic heteroatom containing derivatives, pharmaceutical compositions containing them, their use in the treatment of disorders mediated by one or...
7317035 Tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them  
The present invention relates to novel tetracyclic arylcarbonyl indoles, their derivatives, their analogues, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically...
7312203 1-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof  
The present invention relates to 1-aza-dibenzoazulene derivatives, to their pharmacologically acceptable salts and solvates, to processes and intermediates for the preparation thereof as well as to...
7307080 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage  
The disclosure relates to compounds, pharmaceutical compositions and methods for inhibiting PARP by use of the disclosed compositions. The compounds of the disclosure have the following structures...
7297711 Arylalkyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them  
The present invention relates to novel tetracyclic arylalkyl indoles, their derivatives, their analogues, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically...
7294646 Maxi-k channel blockers, methods of use and process for making the same  
This invention relates to the use of potent potassium channel blockers or a formulation thereof in the treatment of glaucoma and other conditions related to elevated intraocular pressure in the eye...
7276494 Photosensitisers  
A compound for use as a photosensitiser in PDT, in photochemical internalisation in the production of a cancer vaccine or in the diagnosis or detection of medical conditions, the compound having a...
7268155 Photosensitizer conjugates for pathogen targeting  
Conjugate molecules which include photosensitizer compositions conjugated to non-antibody non-affinity pair targeting moieties and methods of making and using such conjugates are described.
7267990 Chelation of charged and uncharged molecules with porphyrin-based compounds  
Porphyrins containing one or more neutral or negatively-charged, closo- or nido-carborane substituents are useful as chelators. The carbon-carbon bonds linking the boron-containing groups to the...
7265100 Separation of regioisomers of metal phthalocyanines  
The present invention refers to a process for the separation of regioisomeric mixtures of metal phthalocyanines of formula (I), to the regioisomers obtained by this process, and their use as...
7262215 N-carbacycle monosubstituted indolocarbazoles as protein kinase inhibitors  
This invention relates to N-carbacycle monosubstituted indolocarbazole compounds. Furthermore, this invention relates to medicaments comprising N-carbacycle monosubstituted indolocarbazoles...
7241796 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease  
The present invention relates to peptidomimetic compounds that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3–NS4A protease. As such, they act by interfering...
7232842 Kinase inhibitors and associated pharmaceutical compositions and methods of use  
The invention provides novel compounds useful as kinase inhibitors or as starting materials And/or intermediates in the synthesis of compounds useful as kinase inhibitors. The compounds have The...
7230026 Selected fused pyrrolocarbazoles  
The present invention relates generally to selected fused pyrrolocarbazoles, including pharmaceutical compositions thereof and methods of treating diseases therewith. The present invention is also...
7214703 Pyrrolidinohydrochinazolines  
Disclosed are compounds of formula (I): or stereoisomers or pharmaceutically acceptable salts thereof, wherein the groups Ar 1 , Ar 2 , A, R 1 , R 2 , R 3 , E 1 , E 2 , X and n are as defined...
7214701 Active substance combinations having insecticidal and acaricdal properties  
The invention relates to insecticidal mixtures for protecting plants against attack by pests comprising (a) compounds of the formula (I) in which W, X, Y, Z, A, B, D and G...
7202255 Substituted [1,4] benzodioxino[2,3-e] isoindole derivatives, method for preparing and pharmaceutical compositions containing same  
Compounds of formula (I): wherein: A is as defined in the description, Y represents a group selected from an oxygen atom and a methylene group, R 2 represents a hydrogen atom and in...
7192650 Element having porphyrin polymer fixed on a substrate and method of preparing the same  
A photo-functional molecule element having, on a substrate, a porphyrin polymer containing covalently-fixed porphyrin units, and the method of preparing the same. The photo-functional molecule...
7189707 Substituted porphyrins  
The present invention relates, in general, to a method of modulating physiological and pathological processes and, in particular, to a method of modulating cellular levels of oxidants and thereby...
7169802 Fused pyrrolocarbazoles  
The present invention relates generally to selected fused pyrrolocarbazoles, including pharmaceutical compositions thereof and methods of treating diseases therewith. The present invention is also...
7163956 Substituted fullerene compositions and their use as antioxidants  
This patent discloses a substituted fullerenes, compositions comprising the same, and their use as antioxidants. The substituted fullerenes comprise a fullerene core (Cn) and at least one of: (i)...
7160873 Texaphyrin coordination compounds and uses thereof  
Novel coordination polymers, their pharmaceutical formulations, useful for treating atheroma, tumors and other neoplastic tissue, as well as other conditions that are responsive to the induction of...
7153848 Inhibitors of HCV replication  
Indole compounds of Formula I are described. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV. Different forms and compositions...
7151108 [3,4-a:3,4-c]carbazole compounds  
A compound selected from those of formula (I): wherein: W 1 represents, together with carbon to which it is bonded, phenyl, pyridyl, Z represents a group of formula U—V as defined in...
7147840 Oxo-bacteriopyropheophorbide-a carboxylic acid and esters thereof  
A compound having the structural formula: where R is H or lower alkyl of 1 through 12 carbon atoms. In general, the compounds of the invention are 13 2 -Oxo-bacteriopyropheophorbide—a...
7144912 Pyrrole-type compounds, compositions, and methods for treating cancer, treating viral diseases and causing immunosuppression  
The present invention relates to novel Pyrrole-Type compounds, compositions comprising Pyrrole-Type compounds, and methods useful for treating or preventing cancer or a neoplastic disorder...
7144879 Substituted metal-phthalocyanines, their preparation and the use thereof  
The present invention is directed to metal-phthalocyanines of general formula (I) to the corresponding conjugates, the processes for their preparation and use in the photodynamic therapy of...
7138391 Hydrophilizable and hydrophilic cyanine dyes  
The present invention provides an IR-absorbing dye of formula (I) or (II): wherein Q 1 , Q 2 , Q 3 and Q 4 are the same or different and are independently selected from a C 3-20 ...
7135193 Liposome compositions of porphyrin photosensitizers  
Liposomal pharmaceutical formulations incorporating porphyrin photosensitizers useful for photodynamic therapy or diagnosis of malignant cells. The liposomal formulations comprise a porphyrin...
7125862 Porphyrin-metal complexes and oxygen infusions containing the same  
A porphyrin metal complex that can form a stable oxygen complex and acts effectively as an oxygen infusion, which comprises: a transition metal ion M of period 4 or 5 coordinating to a porphyrin...